Cargando…

Adenosine regulates radiation therapy-induced anti-tumor immunity

Detalles Bibliográficos
Autores principales:	Wennerberg, Erik, Kawashima, Noriko, Demaria, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649488/ http://dx.doi.org/10.1186/2051-1426-3-S2-P378

Ejemplares similares

Intratumoral IL-15 potentiates radiation-induced anti-tumor immunity
por: Pilones, Karsten, et al.
Publicado: (2015)

Ionizing radiation modifies immune-related molecular profiles of tumor-derived exosomes
por: Diamond, Julie M, et al.
Publicado: (2015)

Anti-tumor characteristics of radiation-induced tumor-infiltrating neutrophils
por: Takeshima, Tsuguhide, et al.
Publicado: (2014)

Dendritic cells cross-presenting tumor-derived antigens are eliminated by invariant natural killer T (iNKT) cells, impairing development of anti-tumor immunity to a mouse carcinoma
por: Pilones, Karsten A, et al.
Publicado: (2013)

Interleukin-15 potentiates human natural killer cells to resist tumor-induced suppression through mTOR-regulated metabolic control
por: Lundqvist, Andreas, et al.
Publicado: (2015)

Immune consequences of CT-guided radiation therapy of mouse mammary tumors
por: Gough, Michael J, et al.
Publicado: (2013)

Detection of antibody therapy-induced anti-tumor immune responses using anti-CD8 immuno-pet
por: Tavare, Richard, et al.
Publicado: (2015)

Fractionated but not single dose radiation releases key signals of in situ tumor vaccination
por: Vanpouille-Box, Claire, et al.
Publicado: (2014)

Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors
por: Rudqvist, Nils-Petter, et al.
Publicado: (2023)

Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system
por: Lhuillier, Claire, et al.
Publicado: (2019)

Barriers to Radiation-Induced In Situ Tumor Vaccination
por: Wennerberg, Erik, et al.
Publicado: (2017)

Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma
por: Patel, Mira, et al.
Publicado: (2015)

Methotrexate, through adenosine release, downregulates tumor necrosis factor alpha-induced synovial fibroblast IL-15 expression and proliferation
por: Miranda, E, et al.
Publicado: (2005)

Modulation of immune cell infiltrate with sunitinib to improve anti-PD1 therapy in preclinical tumor model
por: Rayman, Patricia, et al.
Publicado: (2015)

Activin A is upregulated by radiation in breast cancer cells and promotes conversion of CD4 T cells into regulatory T cells
por: Vanpouille-Box, Claire, et al.
Publicado: (2013)

Anti-tumor effects of anti-PD-L1 therapy in an orthotopic bladder tumor model
por: Lyon, Amanda, et al.
Publicado: (2014)

Adenosine increases during human experimental endotoxemia, but does not influence the immune response and subsequent organ injury
por: Ramakers, B, et al.
Publicado: (2010)

Oncolytic adenovirus improves anti-tumor efficacy of adoptive T cell therapy by breaking tumor-induced immunosuppression and peripheral tolerance
por: Tähtinen, Siri, et al.
Publicado: (2015)

The impact of β-adrenergic signaling on radioresistance and anti-tumor immunity
por: Bucsek, Mark, et al.
Publicado: (2015)

The impact of metabolic stress on anti-tumor immunity in laboratory mice
por: Kokolus, Kathleen M, et al.
Publicado: (2013)

The A2A adenosine receptor regulates the formation of new lymphatic vessels in inflammatory microenvironments
por: Allard, Bertrand, et al.
Publicado: (2015)

Adjuvant inhibition of iAPC function in the tumor microenvironment promotes therapeutic immunity in the setting of vaccination-induced T cell anti-tumor response
por: Antonios, Joseph, et al.
Publicado: (2015)

TGFβ and activin A control regulatory T cells in irradiated tumors
por: Vanpouille-Box, Claire, et al.
Publicado: (2015)

The mechanism of anti-tumor immunity induced by varlilumab, a CD27 agonist mAb, is model dependent
por: He, Li-Zhen, et al.
Publicado: (2015)

Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment
por: Yopp, Adam, et al.
Publicado: (2014)

Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models
por: Spahn, Jessica, et al.
Publicado: (2015)

Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice
por: Johnson, Christopher B, et al.
Publicado: (2014)

Evolutionary design of selective adenosine receptor ligands
por: van der Eelke, Horst, et al.
Publicado: (2010)

Mcl-1 expression influcences CD8+ anti-tumor immunity.
por: Pfannenstiel, Lukas W, et al.
Publicado: (2015)

Talilmogene Iaherparepvec generates systemic T-cell-mediated anti-tumor immunity
por: Piasecki, Julia, et al.
Publicado: (2013)

Effects on tumor immunity of anti-TGF-beta with different isoform specificities
por: Terabe, Masaki, et al.
Publicado: (2014)

Bortezomib enhances anti-tumor T cell immunity by remodeling Notch system
por: Thounaojam, Menaka, et al.
Publicado: (2014)

Checkpoint inhibitors synergize with therapeutic platforms, ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy
por: Albershardt, Tina C, et al.
Publicado: (2015)

Core skin DC signatures control immune tolerance to skin cancer and limit anti-tumor immunity
por: Nirschl, Christopher, et al.
Publicado: (2015)

Anti-EGFR targeted monoclonal antibody isotype influences anti-tumor immunity in head and neck cancer patients
por: Trivedi, Sumita, et al.
Publicado: (2015)

Enhancing anti-tumor immunity through local gene delivery to lymph nodes
por: Dold, Neil M, et al.
Publicado: (2015)

Programming the lymph node microenvironment to enhance anti-tumor T cell immunity in neuroblastoma
por: Gammon, Joshua M, et al.
Publicado: (2015)

Breast tumors induced by high-dose radiation display similar genetic profiles
por: Broeks, A, et al.
Publicado: (2005)

Tumor control by intravenous administration of STING ligand requires combination with precisely timed radiation therapy
por: Baird, Jason, et al.
Publicado: (2015)

Unique changes in the TCR repertoire of tumor-infiltrating lymphocytes underlie the synergy of radiotherapy with CTLA-4 blockade
por: Pilones, Karsten, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gv4l76ubea1gdh3s7f2l44fkor